Automatic diagnosis of severe diseases using artificial intelligence

Aireen is medical device SW based on artificial intelligence. It provides non-invasive, pain-less screening of chronic diseases by analysing digital images of the retina. The retina is the only place in the human body where blood vessels can be seen by the naked eye. Artificial intelligence is cutting-edge breakthrough technology which allows for the precise identification of changes to the retina. It does so using the unique neural network models which Aireen has created on the basis of:


  • Over 1 million images which have been annotated in collaboration with leading retina specialists from prestigious eye clinics.



  • Aireen has been a registered medical device since 2020, launched onto the European Union market.

Team Aireen

Jan Hlaváček

Jan Hlaváček

CEO
David Navrátil

David Navrátil

Founder
Petr Kocian

Petr Kocian

Strategic Partner
Martin Slíva

Martin Slíva

CTO
Renata Ženíšková

Renata Ženíšková

Clinical Researcher
Dana Fillová

Dana Fillová

Clinical Researcher

Advisory board

prof. MUDr. Jakub Hort, Ph.D.

prof. MUDr. Jakub Hort, Ph.D.

prof. MUDr. Martin Prázný CSc., Ph.D.

prof. MUDr. Martin Prázný CSc., Ph.D.

Doc. MUDr. Martin Šín Ph.D., FEBO

Doc. MUDr. Martin Šín Ph.D., FEBO

Our supporters